kb001
mAbexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2008 (NCT00638365)
Timeline
Indications
Mechanism of action
- Low calcium response locus protein VINHIBITOR
pcrV inhibitor
- Pseudomonas aeruginosaINHIBITOR
Pseudomonas aeruginosa inhibitor
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2109536 ↗
Also known as
- humaneered
- kb001
- kb001
- kb-001
- kb001-a
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01695343 | Phase 2 | Dec 1, 2012 | Humanigen |
| NCT00691587 | Phase 1/Phase 2 (Phase 2) | Apr 1, 2008 | Humanigen, University of Paris |
| NCT00638365 | Phase 1/Phase 2 (Phase 2) | Mar 1, 2008 | Humanigen, Stanford University |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Humanigen | For profit | 3 | 3 | 1 | 2008 |
| Stanford University | Academic/Hospital | 1 | 0 | 1 | 2008 |
| University of Paris | Academic/Hospital | 1 | 0 | 1 | 2008 |
3 organizations
Page 1 / 1